24 results on '"Dajko M"'
Search Results
2. The effect of multifactorial lifestyle interventions on cardiovascular risk factors: a systematic review and meta-analysis of trials conducted in the general population and high risk groups
- Author
-
Sisti, L.G., Dajko, M., Campanella, P., Shkurti, E., Ricciardi, W., and de Waure, C.
- Published
- 2018
- Full Text
- View/download PDF
3. Artificial intelligence and big data processing for the development of predictive models to support Covid-19 hospital patients
- Author
-
Miele, L., primary, Dajko, M., additional, Savino, M.C., additional, Calvez, V., additional, Capocchiano, N.D., additional, Liguori, A., additional, Marrone, G., additional, Biolato, M., additional, Patarnello, S., additional, Gasbarrini, A., additional, and Grieco, A., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Impact of lifestyle intervention in cardiovascular prevention: are physical activity advices enough?: Paolo Campanella
- Author
-
Sisti, LG, Dajko, M, Campanella, P, Shkurti, E, Jovanovic, M, Markovic, M, Milenkovic, S, Ricciardi, W, and de Waure, C
- Published
- 2017
- Full Text
- View/download PDF
5. Cost-effectiveness of the adherence with recommendations for clinical monitoring of patients with diabetes
- Author
-
Corrao, G, Rea, F, Mancia, G, Perseghin, G, Merlino, L, Martini, N, Carbone, S, Carle, F, Bucci, A, Dajko, M, Arca, S, Bellentani, D, Bruno, V, Ceccolini, C, De Feo, A, Lispi, L, Mariniello, R, Masullo, M, Medici, F, Pisanti, P, Visca, M, Zanini, R, Di Fiandra, T, Magliocchetti, N, Romano, G, Cantarutti, A, Pugni, P, Davoli, M, Di Martino, M, Lallo, A, Vittori, P, Vuillermin, G, Bernardo, A, Fusciante, A, Belotti, L, De Palma, R, Di Felice, E, Chiandetti, R, Clagnan, E, Del Zotto, S, Di Lenarda, A, Mariotto, A, Prezza, M, Zanier, L, Fusco, D, Marinacci, C, Lora, A, Spazzafumo, L, Pizzi, S, Simiele, M, Massaro, G, Attolini, E, Lepore, V, Petrarolo, V, De Luca, G, Fantaci, G, Pollina Addario, S, Scondotto, S, Bellomo, F, Braga, M, Di Fabrizio, V, Forni, S, Francesconi, P, Profili, F, Avossa, F, Corradin, M, Vigna, S, Dondi, L, Pedrini, A, Piccinni, C, Cosentino, M, Marvulli, M, Maggioni, A, Corrao G., Rea F., Mancia G., Perseghin G., Merlino L., Martini N., Carbone S., Carle F., Bucci A., Dajko M., Arca S., Bellentani D., Bruno V., Ceccolini C., De Feo A., Lispi L., Mariniello R., Masullo M., Medici F., Pisanti P., Visca M., Zanini R., Di Fiandra T., Magliocchetti N., Romano G., Cantarutti A., Pugni P., Davoli M., Di Martino M., Lallo A., Vittori P., Vuillermin G., Bernardo A., Fusciante A., Belotti L., De Palma R., Di Felice E., Chiandetti R., Clagnan E., Del Zotto S., Di Lenarda A., Mariotto A., Prezza M., Zanier L., Fusco D., Marinacci C., Lora A., Spazzafumo L., Pizzi S., Simiele M., Massaro G., Attolini E., Lepore V., Petrarolo V., De Luca G., Fantaci G., Pollina Addario S., Scondotto S., Bellomo F., Braga M., Di Fabrizio V., Forni S., Francesconi P., Profili F., Avossa F., Corradin M., Vigna S., Dondi L., Pedrini A., Piccinni C., Cosentino M., Marvulli M. G., Maggioni A., Corrao, G, Rea, F, Mancia, G, Perseghin, G, Merlino, L, Martini, N, Carbone, S, Carle, F, Bucci, A, Dajko, M, Arca, S, Bellentani, D, Bruno, V, Ceccolini, C, De Feo, A, Lispi, L, Mariniello, R, Masullo, M, Medici, F, Pisanti, P, Visca, M, Zanini, R, Di Fiandra, T, Magliocchetti, N, Romano, G, Cantarutti, A, Pugni, P, Davoli, M, Di Martino, M, Lallo, A, Vittori, P, Vuillermin, G, Bernardo, A, Fusciante, A, Belotti, L, De Palma, R, Di Felice, E, Chiandetti, R, Clagnan, E, Del Zotto, S, Di Lenarda, A, Mariotto, A, Prezza, M, Zanier, L, Fusco, D, Marinacci, C, Lora, A, Spazzafumo, L, Pizzi, S, Simiele, M, Massaro, G, Attolini, E, Lepore, V, Petrarolo, V, De Luca, G, Fantaci, G, Pollina Addario, S, Scondotto, S, Bellomo, F, Braga, M, Di Fabrizio, V, Forni, S, Francesconi, P, Profili, F, Avossa, F, Corradin, M, Vigna, S, Dondi, L, Pedrini, A, Piccinni, C, Cosentino, M, Marvulli, M, Maggioni, A, Corrao G., Rea F., Mancia G., Perseghin G., Merlino L., Martini N., Carbone S., Carle F., Bucci A., Dajko M., Arca S., Bellentani D., Bruno V., Ceccolini C., De Feo A., Lispi L., Mariniello R., Masullo M., Medici F., Pisanti P., Visca M., Zanini R., Di Fiandra T., Magliocchetti N., Romano G., Cantarutti A., Pugni P., Davoli M., Di Martino M., Lallo A., Vittori P., Vuillermin G., Bernardo A., Fusciante A., Belotti L., De Palma R., Di Felice E., Chiandetti R., Clagnan E., Del Zotto S., Di Lenarda A., Mariotto A., Prezza M., Zanier L., Fusco D., Marinacci C., Lora A., Spazzafumo L., Pizzi S., Simiele M., Massaro G., Attolini E., Lepore V., Petrarolo V., De Luca G., Fantaci G., Pollina Addario S., Scondotto S., Bellomo F., Braga M., Di Fabrizio V., Forni S., Francesconi P., Profili F., Avossa F., Corradin M., Vigna S., Dondi L., Pedrini A., Piccinni C., Cosentino M., Marvulli M. G., and Maggioni A.
- Abstract
Background and aims: To validate a set of indicators for monitoring the quality of care of patients with diabetes in ‘real-life’ practice through its relationship with measurable clinical outcomes and healthcare costs. Methods and results: A population-based cohort study was carried out by including the 20,635 patients, residents in the Lombardy Region (Italy), who in the year 2012 were newly taken-in-care for diabetes. Adherence with clinical recommendations (i.e., controls for glycated haemoglobin, lipid profile, urine albumin excretion and serum creatinine) was recorded during the first year after the patient was taken-in-care, and categorized according whether he/she complied with none or almost none (0 or 1), just some (2) or all or almost all (3 or 4) the recommendations, respectively denoted as poor, intermediate and high adherence. Short- and long-term complications of diabetes, and healthcare cost incurred by the National Health Service, were assessed during follow-up. Compared with patients with poor adherence, those with intermediate and high adherence respectively showed (i) a delay in outcome occurrence of 13 days (95% CI, −2 to 27) and 23 days (9–38), and (ii) a lower healthcare cost of 54 € and 77 €. In average, a gain of 18 Euros and 15 Euros for each day free from diabetic complication by increasing adherence respectively from poor to intermediate and from poor to high were observed. Conclusion: Close control of patients with diabetes through regular clinical examinations must be considered the cornerstone of national guidance, national audits, and quality improvement incentive schemes.
- Published
- 2021
6. Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study
- Author
-
Miele, Luca, Grattagliano, I., Lapi, F., Dajko, M., De Magistris, A., Liguori, Antonio, De Matthaeis, Nicoletta, Rossi, A., Gasbarrini, Antonio, Cricelli, Claudio, Grieco, Antonio, Miele L. (ORCID:0000-0003-3464-0068), Liguori A., De Matthaeis N., Gasbarrini A. (ORCID:0000-0002-7278-4823), Cricelli C., Grieco A. (ORCID:0000-0002-0544-8993), Miele, Luca, Grattagliano, I., Lapi, F., Dajko, M., De Magistris, A., Liguori, Antonio, De Matthaeis, Nicoletta, Rossi, A., Gasbarrini, Antonio, Cricelli, Claudio, Grieco, Antonio, Miele L. (ORCID:0000-0003-3464-0068), Liguori A., De Matthaeis N., Gasbarrini A. (ORCID:0000-0002-7278-4823), Cricelli C., and Grieco A. (ORCID:0000-0002-0544-8993)
- Abstract
Background and aims: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing globally. This study aimed to determine the prevalence of NAFLD and the probability of liver fibrosis in Italian primary care services. Methods: We carried out a population-based and nested case–control study including all individuals aged 18 years and above registered at Italian primary care services. Data were collected from the general practitioners' network from 2010 to 2017. NAFLD cases were identified via the ICD-9-CM and Hepatic Steatosis Index score > 36 and were matched each up to 10 controls. Other causes of liver diseases were excluded. The risk of fibrosis was assessed using the FIB-4 and NAFLD fibrosis scores (NFS). Results: NAFLD was present in 9% of the primary care population with high regional variability. Among NAFLD subjects: 25% had diabetes, 10% had chronic kidney disease, 11% had cardiovascular disease and 28% were obese. Furthermore, 30% had at least two comorbidities and 13% had cirrhosis. Once cirrhosis was excluded, the risk of any degree of fibrosis was 13.8% with NFS and 20.5% with FIB-4 in subjects <65 years. Conclusions: Even if there is an identification gap in primary care, recorded cases with NAFLD have a high frequency of associated comorbidities. Despite regional variability, a close relation between cirrhosis and NAFLD exists (OR: 3.48, 95% CI: 3.23–3.76). Therefore, the use of non-invasive tests should be promoted in primary care as a useful tool for the early identification of fibrosis risk, independently of evidence of steatosis.
- Published
- 2022
7. Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)
- Author
-
Miele, Luca, Perna, Alessia, Dajko, M., Zocco, Maria Assunta, De Magistris, A., Nicoletti, Tommaso Filippo, Biolato, Marco, Marrone, Giuseppe, Liguori, Antonio, Maccora, Daria, Valenza, Venanzio, Rossi, Salvatore, Riso, V., Di Natale, Daniele, Gasbarrini, Antonio, Grieco, A., Silvestri, Gabriella, Miele L. (ORCID:0000-0003-3464-0068), Perna A., Zocco M. A. (ORCID:0000-0002-0814-9542), Nicoletti T. F., Biolato M., Marrone G., Liguori A., Maccora D., Valenza V. (ORCID:0000-0002-0023-6625), Rossi S., Di Natale D., Gasbarrini A. (ORCID:0000-0002-7278-4823), Silvestri G. (ORCID:0000-0002-1950-1468), Miele, Luca, Perna, Alessia, Dajko, M., Zocco, Maria Assunta, De Magistris, A., Nicoletti, Tommaso Filippo, Biolato, Marco, Marrone, Giuseppe, Liguori, Antonio, Maccora, Daria, Valenza, Venanzio, Rossi, Salvatore, Riso, V., Di Natale, Daniele, Gasbarrini, Antonio, Grieco, A., Silvestri, Gabriella, Miele L. (ORCID:0000-0003-3464-0068), Perna A., Zocco M. A. (ORCID:0000-0002-0814-9542), Nicoletti T. F., Biolato M., Marrone G., Liguori A., Maccora D., Valenza V. (ORCID:0000-0002-0023-6625), Rossi S., Di Natale D., Gasbarrini A. (ORCID:0000-0002-7278-4823), and Silvestri G. (ORCID:0000-0002-1950-1468)
- Abstract
Background: Myotonic dystrophy type 1 (DM1) is a rare inherited neuromuscular disease associated with insulin resistance, and its association with metabolically associated fatty liver disease (MAFLD) has never been explored in prospective studies. The aim of this study was to assess the clinical features of MAFLD in DM1 patients. Methods: We investigated the prevalence and the diagnostic features of MAFLD in a cohort of 29 outpatient fully characterized DM1 patients; afterward, we compared the selected cohort of DM1-MAFLD individuals with a propensity-matched cohort of non-DM1-MAFLD Results: 13/29 (44.83%) DM1 patients received a clinical diagnosis of MAFLD. Compared to DM1 patients with normal liver, DM1-MAFLD individuals showed a higher male prevalence (p = 0.008), BMI (p = 0.014), HOMA score (p = 0.012), and GGT levels (p = 0.050). The statistical comparison showed that the DM1-MAFLD group had a more severe MAFLD according to the FIB4 score than non-DM1-MAFLD patients. This association of a more severe form of liver disease with DM1 remained significant after logistic regression analysis (OR: 6.12, 95% CI 1.44- 26.55).
- Published
- 2021
8. Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study
- Author
-
Miele, L., primary, Cricelli, C., additional, Lapi, F., additional, Grattagliano, I., additional, Dajko, M., additional, Liguori, A., additional, De Magistris, A., additional, Napodano, C., additional, Marrone, G., additional, Biolato, M., additional, Rossi, A., additional, Rapaccini, G., additional, Grieco, A., additional, and Gasbarrini, A., additional
- Published
- 2021
- Full Text
- View/download PDF
9. General Practitioner databaSe NAFLD (GPS-NAFLD) study: Italian regional variability of the NAFLD prevalence rate
- Author
-
Miele, L., primary, Grattagliano, I., additional, Lapi, F., additional, Dajko, M., additional, Liguori, A., additional, De Magistris, A., additional, Napodano, C., additional, Rossi, A., additional, Rapaccini, G., additional, Gasbarrini, A., additional, Cricelli, C., additional, and Grieco, A., additional
- Published
- 2021
- Full Text
- View/download PDF
10. General Practitioner databaSe NAFLD (GPS-NAFLD) Study: prevalence of advanced liver fibrosis among Italian primary care patients with NAFLD
- Author
-
Miele, L., primary, Cricelli, C., additional, Lapi, F., additional, Grattagliano, I., additional, Dajko, M., additional, Liguori, A., additional, De Magistris, A., additional, Napodano, C., additional, Rossi, A., additional, Rapaccini, G., additional, Gasbarrini, A., additional, and Grieco, A., additional
- Published
- 2021
- Full Text
- View/download PDF
11. Correlation of the transaminases alteration with the clinical severity of patients with COVID- 19: A meta-analysis of the first global outbreak
- Author
-
Miele, L., primary, Dajko, M., additional, Marrone, G., additional, De Magistris, A., additional, Biolato, M., additional, Liguori, A., additional, Rapaccini, G.L., additional, Gasbarrini, G., additional, and Grieco, A., additional
- Published
- 2021
- Full Text
- View/download PDF
12. PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY
- Author
-
Miele, Luca, Lapi, F, Grattagliano, I, Liguori, Antonio, Dajko, M, Marrone, G, Biolato, Marco, Napodano, Cecilia, De Magistris, A, Rapaccini, Gian Ludovico, Rossi, A, Gasbarrini, Antonio, Cricelli, Claudio, and Grieco, A
- Subjects
N/A ,Settore MED/12 - GASTROENTEROLOGIA - Published
- 2020
13. PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY
- Author
-
Miele, L, Lapi, F, Grattagliano, I, Liguori, A, Dajko, M, Marrone, G, Biolato, M, Napodano, C, De Magistris, A, Rapaccini, G, Rossi, A, Gasbarrini, A, Cricelli, C, Grieco, A, Miele, L (ORCID:0000-0003-3464-0068), Napodano, C (ORCID:0000-0002-8720-6284), Rapaccini, G (ORCID:0000-0002-6467-857X), Gasbarrini, A (ORCID:0000-0002-7278-4823), Miele, L, Lapi, F, Grattagliano, I, Liguori, A, Dajko, M, Marrone, G, Biolato, M, Napodano, C, De Magistris, A, Rapaccini, G, Rossi, A, Gasbarrini, A, Cricelli, C, Grieco, A, Miele, L (ORCID:0000-0003-3464-0068), Napodano, C (ORCID:0000-0002-8720-6284), Rapaccini, G (ORCID:0000-0002-6467-857X), and Gasbarrini, A (ORCID:0000-0002-7278-4823)
- Abstract
N/A
- Published
- 2020
14. Streptococcus pneumoniae in hospitalized patients with pneumonia: epidemiology and implications
- Author
-
Dajko, M, primary, Poscia, A, additional, Posteraro, B, additional, Speziale, D, additional, Volpe, M, additional, Ricciardi, W, additional, and de Waure, C, additional
- Published
- 2020
- Full Text
- View/download PDF
15. The effect of multifactorial lifestyle interventions on cardiovascular risk factors: a systematic review and meta-analysis of trials conducted in the general population and high risk groups
- Author
-
Sisti, Leuconoe Grazia, Dajko, M., Campanella, P., Shkurti, E., Ricciardi, Walter, de Waure, C., Sisti, L. G., Ricciardi, W. (ORCID:0000-0002-5655-688X), Sisti, Leuconoe Grazia, Dajko, M., Campanella, P., Shkurti, E., Ricciardi, Walter, de Waure, C., Sisti, L. G., and Ricciardi, W. (ORCID:0000-0002-5655-688X)
- Abstract
Cardiovascular diseases (CVDs) are the leading cause of premature mortality and disability accounting for one third of all deaths worldwide with considerable impacts on economics and on the quality of life. The evidence suggests that a multifactorial lifestyle intervention might have a role in the CVDs risk reduction, especially in the risk populations, nonetheless the effects on modifiable CVDs risk factors have not been completely explored. Our work aimed at evaluating the impact of multifactorial lifestyle interventions on cardiovascular risk modification, both in the general and risk population. A systematic review and meta-analysis of the randomized controlled trials (RCTs) were performed by including articles published up to April 16th, 2016. RCTs were selected if they had investigated the impact of multifactorial lifestyle interventions on lipids, blood pressure, BMI and waist circumference, smoking and physical activity. Changes in the level of modifiable risk factors from baseline were evaluated. Search resulted in 19,847 studies, of which 36 were included in the analysis. Compared to a usual care, the multifactorial lifestyle intervention is able to lower the blood pressure, total cholesterol, BMI and waist circumference, at both 6 and 12 months, and to increase physical activity at 12 months. Better results were obtained in primary prevention and in moderate and high risk groups. Multifactorial lifestyle interventions clearly represent a valid tool for reducing the cardiovascular risk factors and should be implemented in the risk groups and in primary prevention.
- Published
- 2018
16. Hormonal deficiencies in heart failure with preserved ejection fraction: prevalence and impact on diastolic dysfunction: a pilot study.
- Author
-
FAVUZZI, A. M. R., VENUTI, A., BRUNO, C., NICOLAZZI, M. A., FUORLO, M., DAJKO, M., DE WAURE, C., LANDOLFI, R., and MANCINI, A.
- Abstract
OBJECTIVE: In heart failure with reduced ejection fraction, catabolic mechanisms have a strong negative impact on mortality and morbidity. The relationship between anabolic hormonal deficiency, thyroid function, and heart failure with preserved ejection fraction (HFpEF) has still been poorly investigated. Therefore, we aimed to define the multi-hormonal deficiency prevalence in HFpEF patients and the relationships between hormonal deficiency and echocardiographic indexes. PATIENTS AND METHODS: Plasma levels of N-terminal pro-brain natriuretic peptide, fasting glucose, thyroid-stimulating hormone, free triiodothyronine (T3), free thyroxine, insulin-like growth factor-1, dehydroepiandrosterone-sulfate (DHEA-S), total testosterone (only in male subjects) in 40 patients with HFpEF were evaluated. An echocardiographic evaluation was performed. RESULTS: One (2.5%) patient (2.5%) had no hormonal deficiencies; 8 (20%) patients had deficits of one hormone, 18 patients (45%) of two axes, 12 patients (30%) of three axes, and one patient (2.5%) of all four axes. Among them, 97.5% had DHEA-S deficiency, 67.5% IGF-1 deficiency, 37% testosterone deficiency, 22.5% a "Low T3 syndrome", and 20% subclinical hypothyroidism. Patients with IGF-1 deficit showed higher left atrial volume values, systolic pulmonary artery pressure (SPAP), tricuspid peak velocity (TPV), and lower tricuspid annular plane systolic excursion (TAPSE) and TAPSE/SPAP ratio values. Patients with testosterone deficiency had higher SPAP and TPV. Patients with low T3 syndrome had higher value of right ventricular mid cavity diameter. Hormonal dysfunction was independent from the presence of comorbidities and no difference between male and female subjects was noted. CONCLUSIONS: Multi-hormonal deficiencies are associated with right ventricular dysfunction and diastolic dysfunction in patients with HFpEF. [ABSTRACT FROM AUTHOR]
- Published
- 2020
17. Microbiological ascertainment in patients with pneumonia: is there room for improvement?
- Author
-
Dajko, M, primary, Poscia, A, additional, Posteraro, B, additional, Speziale, D, additional, Volpe, M, additional, Ricciardi, W, additional, and de Waure, C, additional
- Published
- 2017
- Full Text
- View/download PDF
18. Cost-effectiveness of the adherence with recommendations for clinical monitoring of patients with diabetes
- Author
-
Giovanni Corrao, Federico Rea, Giuseppe Mancia, Gianluca Perseghin, Luca Merlino, Nello Martini, Simona Carbone, Flavia Carle, Andrea Bucci, Marianxhela Dajko, Silvia Arcà, Donata Bellentani, Velia Bruno, Carla Ceccolini, Angela De Feo, Lucia Lispi, Rosanna Mariniello, Maurizio Masullo, Federica Medici, Paola Pisanti, Modesta Visca, Rinaldo Zanini, Teresa Di Fiandra, Natalia Magliocchetti, Giovanna Romano, Anna Cantarutti, Pietro Pugni, Marina Davoli, Mirko Di Martino, Adele Lallo, Patrizia Vittori, Giuliana Vuillermin, Alfonso Bernardo, Anna Fusciante, Laura Belotti, Rossana De Palma, Enza Di Felice, Roberta Chiandetti, Elena Clagnan, Stefania Del Zotto, Andrea Di Lenarda, Aldo Mariotto, Marisa Prezza, Loris Zanier, Danilo Fusco, Chiara Marinacci, Antonio Lora, Liana Spazzafumo, Simone Pizzi, Maria Simiele, Giuseppe Massaro, Ettore Attolini, Vito Lepore, Vito Petrarolo, Giovanni De Luca, Giovanna Fantaci, Sebastiano Pollina Addario, Salvatore Scondotto, Francesco Bellomo, Mario Braga, Valeria Di Fabrizio, Silvia Forni, Paolo Francesconi, Francesco Profili, Francesco Avossa, Matteo Corradin, Silvia Vigna, Letizia Dondi, Antonella Pedrini, Carlo Piccinni, Mimma Cosentino, Maria G. Marvulli, Aldo Maggioni, Corrao, G, Rea, F, Mancia, G, Perseghin, G, Merlino, L, Martini, N, Carbone, S, Carle, F, Bucci, A, Dajko, M, Arca, S, Bellentani, D, Bruno, V, Ceccolini, C, De Feo, A, Lispi, L, Mariniello, R, Masullo, M, Medici, F, Pisanti, P, Visca, M, Zanini, R, Di Fiandra, T, Magliocchetti, N, Romano, G, Cantarutti, A, Pugni, P, Davoli, M, Di Martino, M, Lallo, A, Vittori, P, Vuillermin, G, Bernardo, A, Fusciante, A, Belotti, L, De Palma, R, Di Felice, E, Chiandetti, R, Clagnan, E, Del Zotto, S, Di Lenarda, A, Mariotto, A, Prezza, M, Zanier, L, Fusco, D, Marinacci, C, Lora, A, Spazzafumo, L, Pizzi, S, Simiele, M, Massaro, G, Attolini, E, Lepore, V, Petrarolo, V, De Luca, G, Fantaci, G, Pollina Addario, S, Scondotto, S, Bellomo, F, Braga, M, Di Fabrizio, V, Forni, S, Francesconi, P, Profili, F, Avossa, F, Corradin, M, Vigna, S, Dondi, L, Pedrini, A, Piccinni, C, Cosentino, M, Marvulli, M, and Maggioni, A
- Subjects
Diagnostic Screening Programs ,Male ,medicine.medical_specialty ,Time Factors ,Databases, Factual ,National Health Programs ,Cost effectiveness ,Endocrinology, Diabetes and Metabolism ,Cost-Benefit Analysis ,Population ,Medicine (miscellaneous) ,Audit ,Diagnostic Techniques, Ophthalmological ,Diabete ,Kidney Function Tests ,Cost Savings ,Predictive Value of Tests ,Diabetes mellitus ,Health care ,medicine ,Diabetes Mellitus ,Healthcare cost ,Humans ,education ,Aged ,Incremental cost-effectiveness ratio ,education.field_of_study ,Nutrition and Dietetics ,medicine.diagnostic_test ,business.industry ,Periodic examination ,Health Care Costs ,Middle Aged ,medicine.disease ,Prognosis ,Population-based cohort study ,Real-world ,Italy ,Cost-effectivene ,Emergency medicine ,Patient Compliance ,Female ,Cardiology and Cardiovascular Medicine ,business ,Lipid profile ,Complication ,Blood Chemical Analysis ,Cohort study - Abstract
Background and aims To validate a set of indicators for monitoring the quality of care of patients with diabetes in ‘real-life’ practice through its relationship with measurable clinical outcomes and healthcare costs. Methods and results A population-based cohort study was carried out by including the 20,635 patients, residents in the Lombardy Region (Italy), who in the year 2012 were newly taken-in-care for diabetes. Adherence with clinical recommendations (i.e., controls for glycated haemoglobin, lipid profile, urine albumin excretion and serum creatinine) was recorded during the first year after the patient was taken-in-care, and categorized according whether he/she complied with none or almost none (0 or 1), just some (2) or all or almost all (3 or 4) the recommendations, respectively denoted as poor, intermediate and high adherence. Short- and long-term complications of diabetes, and healthcare cost incurred by the National Health Service, were assessed during follow-up. Compared with patients with poor adherence, those with intermediate and high adherence respectively showed (i) a delay in outcome occurrence of 13 days (95% CI, -2 to 27) and 23 days (9 to 38), and (ii) a lower healthcare cost of 54 € and 77 €. In average, a gain of 18 Euros and 15 Euros for each day free from diabetic complication by increasing adherence respectively from poor to intermediate and from poor to high were observed. Conclusion Close control of patients with diabetes through regular clinical examinations must be considered the cornerstone of national guidance, national audits, and quality improvement incentive schemes.
- Published
- 2021
19. Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves.
- Author
-
Miele L, Dajko M, Savino MC, Capocchiano ND, Calvez V, Liguori A, Masciocchi C, Vetrone L, Mignini I, Schepis T, Marrone G, Biolato M, Cesario A, Patarnello S, Damiani A, Grieco A, Valentini V, and Gasbarrini A
- Subjects
- Adult, Humans, SARS-CoV-2, RNA, Viral, Hospital Mortality, Cohort Studies, Pandemics, Artificial Intelligence, Retrospective Studies, COVID-19
- Abstract
Increased values of the FIB-4 index appear to be associated with poor clinical outcomes in COVID-19 patients. This study aimed to develop and validate predictive mortality models, using data upon admission of hospitalized patients in four COVID-19 waves between March 2020 and January 2022. A single-center cohort study was performed on consecutive adult patients with Covid-19 admitted at the Fondazione Policlinico Gemelli IRCCS (Rome, Italy). Artificial intelligence and big data processing were used to retrieve data. Patients and clinical characteristics of patients with available FIB-4 data derived from the Gemelli Generator Real World Data (G2 RWD) were used to develop predictive mortality models during the four waves of the COVID-19 pandemic. A logistic regression model was applied to the training and test set (75%:25%). The model's performance was assessed by receiver operating characteristic (ROC) curves. A total of 4936 patients were included. Hypertension (38.4%), cancer (12.15%) and diabetes (16.3%) were the most common comorbidities. 23.9% of patients were admitted to ICU, and 12.6% had mechanical ventilation. During the study period, 762 patients (15.4%) died. We developed a multivariable logistic regression model on patient data from all waves, which showed that the FIB-4 score > 2.53 was associated with increased mortality risk (OR = 4.53, 95% CI 2.83-7.25; p ≤ 0.001). These data may be useful in the risk stratification at the admission of hospitalized patients with COVID-19., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
20. Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study: GPS-NAFLD Study.
- Author
-
Miele L, Grattagliano I, Lapi F, Dajko M, De Magistris A, Liguori A, De Matthaeis N, Rossi A, Gasbarrini A, Cricelli C, and Grieco A
- Subjects
- Humans, Case-Control Studies, Severity of Illness Index, Risk Factors, Liver Cirrhosis epidemiology, Liver Cirrhosis etiology, Primary Health Care, Fibrosis, Non-alcoholic Fatty Liver Disease diagnosis, Non-alcoholic Fatty Liver Disease epidemiology, Non-alcoholic Fatty Liver Disease complications
- Abstract
Background and Aims: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing globally. This study aimed to determine the prevalence of NAFLD and the probability of liver fibrosis in Italian primary care services., Methods: We carried out a population-based and nested case-control study including all individuals aged 18 years and above registered at Italian primary care services. Data were collected from the general practitioners' network from 2010 to 2017. NAFLD cases were identified via the ICD-9-CM and Hepatic Steatosis Index score > 36 and were matched each up to 10 controls. Other causes of liver diseases were excluded. The risk of fibrosis was assessed using the FIB-4 and NAFLD fibrosis scores (NFS)., Results: NAFLD was present in 9% of the primary care population with high regional variability. Among NAFLD subjects: 25% had diabetes, 10% had chronic kidney disease, 11% had cardiovascular disease and 28% were obese. Furthermore, 30% had at least two comorbidities and 13% had cirrhosis. Once cirrhosis was excluded, the risk of any degree of fibrosis was 13.8% with NFS and 20.5% with FIB-4 in subjects <65 years., Conclusions: Even if there is an identification gap in primary care, recorded cases with NAFLD have a high frequency of associated comorbidities. Despite regional variability, a close relation between cirrhosis and NAFLD exists (OR: 3.48, 95% CI: 3.23-3.76). Therefore, the use of non-invasive tests should be promoted in primary care as a useful tool for the early identification of fibrosis risk, independently of evidence of steatosis., (© 2022 The Authors. Liver International published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
21. Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1).
- Author
-
Miele L, Perna A, Dajko M, Zocco MA, De Magistris A, Nicoletti TF, Biolato M, Marrone G, Liguori A, Maccora D, Valenza V, Rossi S, Riso V, Di Natale D, Gasbarrini A, Grieco A, and Silvestri G
- Subjects
- Adult, Case-Control Studies, Comorbidity, Female, Humans, Insulin Resistance, Liver Cirrhosis epidemiology, Male, Middle Aged, Myotonic Dystrophy epidemiology, Non-alcoholic Fatty Liver Disease epidemiology, Prevalence, Prospective Studies, Myotonic Dystrophy physiopathology, Non-alcoholic Fatty Liver Disease physiopathology
- Abstract
Background: Myotonic dystrophy type 1 (DM1) is a rare inherited neuromuscular disease associated with insulin resistance, and its association with metabolically associated fatty liver disease (MAFLD) has never been explored in prospective studies. The aim of this study was to assess the clinical features of MAFLD in DM1 patients., Methods: We investigated the prevalence and the diagnostic features of MAFLD in a cohort of 29 outpatient fully characterized DM1 patients; afterward, we compared the selected cohort of DM1-MAFLD individuals with a propensity-matched cohort of non-DM1-MAFLD RESULTS: 13/29 (44.83%) DM1 patients received a clinical diagnosis of MAFLD. Compared to DM1 patients with normal liver, DM1-MAFLD individuals showed a higher male prevalence (p = 0.008), BMI (p = 0.014), HOMA score (p = 0.012), and GGT levels (p = 0.050). The statistical comparison showed that the DM1-MAFLD group had a more severe MAFLD according to the FIB4 score than non-DM1-MAFLD patients. This association of a more severe form of liver disease with DM1 remained significant after logistic regression analysis (OR: 6.12, 95% CI 1.44- 26.55)., Competing Interests: Conflict of interest None declared., (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. The prognostic value of anterior commissure involvement in T1 glottic cancer: A systematic review and meta-analysis.
- Author
-
Tulli M, Re M, Bondi S, Ferrante L, Dajko M, Giordano L, Gioacchini FM, Galli A, and Bussi M
- Subjects
- Carcinoma, Squamous Cell therapy, Humans, Laryngeal Neoplasms therapy, Neoplasm Staging, Observational Studies as Topic, Prognosis, Carcinoma, Squamous Cell pathology, Glottis pathology, Laryngeal Neoplasms pathology
- Abstract
Objective: The anterior commissure is considered a laryngeal subsite, but it is not taken into account in the current T-staging system. The impact of anterior commissure involvement (ACI) on the oncologic outcomes of T1 glottic tumors has not been well defined and remains controversial. The aim of this study was to assess the influence of ACI in the prognosis of T1 glottic tumors., Methods: A systematic review and meta-analysis of observational studies was performed by including studies published up to July 2019. Studies were selected if they had investigated the local control rate (LCR) at 5 years of clinical stage I (T1 and N0) glottic squamous cell carcinoma with and without ACI. The difference in LCR at 5 years between T1 glottic tumors without and with ACI was evaluated., Results: The meta-analysis showed that the difference in LCR at 5 years between T1 glottic tumors without and with ACI is 12% (95% confidence interval: 8%-16%, p < 0,0001, I
2 = 34.81%)., Conclusions: Our study pointed out that the anterior commissure involvement is a negative prognostic factor in LCR at 5 years for T1 glottic tumors. Our results suggest the need to consider ACI in the T staging of glottic tumors. Laryngoscope, 130:1932-1940, 2020., (© 2019 The American Laryngological, Rhinological and Otological Society, Inc.)- Published
- 2020
- Full Text
- View/download PDF
23. Microbiological ascertainment in patients with pneumonia: the experience of a teaching hospital in Rome.
- Author
-
Dajko M, Poscia A, Posteraro B, Speziale D, Volpe M, Mancinelli S, Ricciardi W, and de Waure C
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Body Fluids microbiology, Body Fluids virology, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections surgery, Community-Acquired Infections therapy, Comorbidity, Emergencies, Female, Hospital Mortality, Humans, Intensive Care Units statistics & numerical data, Male, Middle Aged, Patient Admission statistics & numerical data, Patient Discharge statistics & numerical data, Pneumonia epidemiology, Pneumonia surgery, Pneumonia therapy, Respiration, Artificial, Retrospective Studies, Rome, Young Adult, Hospitals, Teaching statistics & numerical data, Hospitals, Urban statistics & numerical data, Pneumonia microbiology
- Abstract
Objectives: Pneumonia still remains a problem from the clinical and public health viewpoint because of the relevant epidemiological burden. The etiological diagnosis is important in the light of avoiding unnecessary antibiotic treatment and choosing the most appropriate therapeutical approach. This study is aimed at providing evidence on the proportion of microbiological ascertainment in pneumonia-related hospitalizations in one of the most important teaching hospitals in Rome., Methods: The study relied on the record linkage of two administrative databases of the same hospital: the electronic hospital discharge register and the microbiology laboratory surveillance database., Results: 2819 records were identified, where 46% had a microbiological ascertainment, significantly higher in males than in females (51% vs 40%) and in cases of pneumonia reported in secondary diagnosis instead of primary diagnosis (52% vs 42%). Medical patients had significantly lower proportion of ascertainment compared to surgical patients (43% vs 67%) whereas there were not differences between patients with emergency and elective admission. The overall mortality was 17%. Mortality was significantly higher: in surgical compared to medical patients (27% vs 15%), in ventilated compared to not ventilated patients (41% vs 11%), in cases with secondary diagnosis of pneumonia compared to a primary diagnosis (23% vs 11% ) and in hospitalized in intensive care unit-ICU- rather than in non-ICU (71% vs 12%)., Conclusion: The proportion of microbiological ascertaiment in pneumonia remains less than 50%. Albeit in line with other evidence, this result should call the attention on the impact of unknown etiological diagnosis on antibiotic treatment and resistance.
- Published
- 2020
- Full Text
- View/download PDF
24. A simple freezing and storage method to preserve the stimulating function of leukocytes in the mixed leukocyte reaction.
- Author
-
Osoba D, Falk J, Dajko M, and Richardson J
- Subjects
- Humans, Lymphocyte Activation, Time Factors, Freezing, Lymphocyte Culture Test, Mixed, Tissue Preservation methods
- Abstract
Human peripheral blood leukocytes retain their capacity to function as stimulating cells in the one way MLR after freezing and storage at - 70 degrees C by a simple and inexpensive method. This storage method facilitates the use of a standard stimulating pool of cells from three donors which may provide a quantitative assay for testing the ability of cells to respond to allogeneic cells in culture.
- Published
- 1975
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.